WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
1. (WO2010139352) LIPOPOLYSACCHARIDE OF OCHROBACTRUM INTERMEDIUM AND THEIR USE AS IMMUNOSTIMULANT OF MAMMALIANS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2010/139352 International Application No.: PCT/EP2009/009342
Publication Date: 09.12.2010 International Filing Date: 31.12.2009
Chapter 2 Demand Filed: 04.04.2011
IPC:
A61K 31/739 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
739
Lipopolysaccharides
Applicants: OVEJERO GUISASOLA, Juan lgnacio[ES/ES]; ES (UsOnly)
FRESNO ESCUDERO, Manuel[ES/ES]; ES (UsOnly)
LABORATORIOS OVEJERO, S.A.[ES/ES]; Ctra. Leόn-Vilecha, 30 E-24005 León, ES (AllExceptUS)
Inventors: OVEJERO GUISASOLA, Juan lgnacio; ES
FRESNO ESCUDERO, Manuel; ES
Agent: TEMIÑO CENICEROS, lgnacio; Abril Abogados, S.l. C/ Amador de los Rios 1-1º E-28010 Madrid, ES
Priority Data:
P200930265 04.06.2009ES
Title (EN) LIPOPOLYSACCHARIDE OF OCHROBACTRUM INTERMEDIUM AND THEIR USE AS IMMUNOSTIMULANT OF MAMMALIANS
(FR) LIPOPOLYSACCHARIDE D'OCHROBACTRUM INTERMEDIUM ET SON UTILISATION COMME IMMUNO-STIMULANT CHEZ LES MAMMIFÈRES
Abstract:
(EN) The present invention relates to the isolation, purification and characterization of the Lipopolysaccharide (LPS) from Ochrobactrum intermedium strain LMG3306, and their use as immunostimulant of mammalians, the process for the preparation of a pharmaceutical compound for the treatment and/or prevention of the sepsis and adjuvant for a vaccine in immunosupressed animals and against Leishmania.
(FR) La présente invention concerne l'isolement, la purification et la caractérisation du Lipopolysaccharide (LPS) à partir de la souche LMG3306 d'Ochrobactrum intermedium, et son utilisation comme immuno-stimulant chez les mammifères, le procédé de préparation d'un composé pharmaceutique destiné au traitement et/ou à la prévention de la sepsie et d'un adjuvant pour un vaccin destiné à des animaux immunodéprimés et contre la Leishmania.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)